Integrin-Mediated Drug Resistance in Multiple Myeloma

References

• Clark E A, Brugge J S. Integrins and signal transduc-tion pathways: the road taken. Science 1995; 268: 233–239, 5208
   PubMed Web of Science ®Google Scholar
• Hynes R O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69(1)11–25
   PubMed Web of Science ®Google Scholar
• Malik R K. Regulation of apoptosis by integrin receptors. Journal of Ped. Hem/Onc. 1997; 19: 541–545
   PubMed Web of Science ®Google Scholar
• Dalton W S. Mechanisms of drug resistance in hema-tologic malignancies. Semin. Hemarol. 1997; 34(4 Suppl 5)3–8
   PubMed Web of Science ®Google Scholar
• Broxterman H J, Giaccone A G, Lankelma J. Multid-rug resistance proteins and other transport-related resistance to natural product agents. Curr. Opin. Onc. 1995; 7(6)532–540
   PubMedGoogle Scholar
• Barlogie B, Epstein J, Selvanayagam P, Alexanian R. Plasma cell myeloma: new biological insights and advances in therapy. Blood 1989; 73(4)865–879
   PubMed Web of Science ®Google Scholar
• Teicher B A, Herman T S, Holden S A, Wang Y, Pfeffer M R, Crawford J W, Frei E, III. Tumor resistance to alkylat-ing agents conferred by mechanisms operative only in vivo. Science 1990; 247: 1457–61, 4949 pt. 1
   PubMed Web of Science ®Google Scholar
• Bradstock K F, Gottlieb D J. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk. Lymph. 1995; 18(1–2)1–16
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Gregoretti M G, Merico F, Gorrardi D, Ghia P, Parvis G, Bergui L. Bone marrow microenvironment and the progression of multiple myeloma. Leuk. Lymph. 1992; 8(1–2)15–22
   PubMed Web of Science ®Google Scholar
• Barker H F, Ball J, Drew M, Hamilton M S, Franklin I M. The role of adhesion molecules in multiple myeloma. Leuk. Lymph. 1992; 8(3)189–196
   PubMed Web of Science ®Google Scholar
• Uchiyama H, Barut B A, Chauhan D, Cannistra S A, Anderson K C. Characterization of adhesion molecules on human myeloma cell lines. Blood 1992; 90(9)2306–2314
   Google Scholar
• St Croix B, Kerbel R S. Cell adhesion and drug resistance in cancer. Curr. Opin. Oncol. 1997; 9(6)549–556
   PubMedGoogle Scholar
• Lagneaux L, Delforge A, Bron D, De Bruyn C, Strykmans P. Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normanl bone marrow stromal cells. Blood 1998; 91(7)2387–2396
   PubMed Web of Science ®Google Scholar
• Kibler C, Schermutzki F, Waller H D, Timpl R, Muller C A, Klein G. Adhesive interactions of human multiple myeloma cell lines with different extracellular matrix molecules. Cell Adhes. Commun. 1998; 5: 307–23
   PubMed Web of Science ®Google Scholar
• Damiano J S, Cress A E, Hazlehurst L A, Shtil A A, Dalton W S. Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999; 93(5)1658–1667
   PubMed Web of Science ®Google Scholar
• Grigorieva I, Thomas X, Epstein J. The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone. Exp. Hematol. 1998; 26(7)597–603
   PubMed Web of Science ®Google Scholar
• Zhang Z, Vuori K, Reed J C, Ruoslahti E. The alpha5 betal integrin suports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 1995; 92(13)6161–6165
   PubMed Web of Science ®Google Scholar
• Higashimoto I, Chihara J, Kakazu T, Kawabata M, Nakajuma S, Osame M. Regulation of eosinophil cell death by adhesion to fibronectin. Int. Arch. Allergy Immunol. 1996; 111(1)66–69
   PubMedGoogle Scholar
• Fukai F, Mashimo M, Akiyama K, Goto T, Tanuma S -I, Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived anti-adhesive peptide. Exp. Cell Res. 1998; 242(1)92–99
   PubMed Web of Science ®Google Scholar
• Bellamy W T, Dalton W S, Gleason M C, Grogan T M, Trent J M. Development and characterization of a melpha-Ian-resistant human multiple myeloma cell line. Cancer Res. 1991; 51(3)995–1002
   PubMed Web of Science ®Google Scholar
• Dalton W S, Salmon S E. Drug resistance in myeloma: mechanisms and approaches to circumvention. Hematol. Oncol. Clin. North Am. 1992; 6: 383–93
   PubMed Web of Science ®Google Scholar
• Wang H, Jiang Zg, Wong Y W, Dalton W S, Futscher B W, Chan V T. Decreased CP-I (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226. Biochem. Biophys. Res. Commun. 1997; 237(2)217–24
   PubMed Web of Science ®Google Scholar
• Zaitseva M B, Mojcik C F, Salomon S R, Shevach E M, Gold-ing H. Co-ligation of α4β1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis. Int. Immun. 1998; 10(10)1551–1561
   PubMed Web of Science ®Google Scholar
• Hughes P E, Pfaff M. Integrin affinity modulation. Trends Cell Biol. 1998; 8(9)359–364
   PubMed Web of Science ®Google Scholar
• Gailit J, Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. J. Biol. Chem. 1988; 263(26)12927–12932
   PubMed Web of Science ®Google Scholar
• Arroyo A G, Sanchez-Mdteos P, Campanero M R, Mar-tin-Padura I, Dejana E, Sanchez-Madrid F. Regulation of the VLA integrin-ligand interactions through the betal subunit. J. Cell Biol. 1992; 117(3)659–670
   PubMed Web of Science ®Google Scholar
• Altieri D C, Bader R, Mannucci P M, Edginton T S. Oli-gospecificty of the cellular adhesion recepctor Mac-1 encompasses recognition specificity for fibrinogen. J Cell Biol. 1988; 107(5)1893–1900
   PubMed Web of Science ®Google Scholar
• Pulido R, Elices M J, Campanero M R, Osbom L, Schiffer S, Garcia-Pardo A, Lobb R, Hemler M E, Sanchez-Madrid F. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J. Biol. Chem. 1991; 266(16)10241–10245
   PubMed Web of Science ®Google Scholar
• Stewart M, Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J. Cell Biochem. 1996; 61(4)554–561
   PubMed Web of Science ®Google Scholar
• Stewart M P, McDowall A, Hogg N. LFA-I-mediated adhesion is regulated by cytoskeletal restraint and by a Ca2+-dependent protease, calpain. J. Cell Biol. 1998; 140(3)699–707
   PubMed Web of Science ®Google Scholar
• Kucik D F, Dustin M L, Miller J M, Brown E J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-I in cultured lymphocytes. J. Clin. Invest. 1996; 97(9)2139–2144
   PubMed Web of Science ®Google Scholar
• Sethi T, Rintoul R C, Moore S M, MacKinnon A C, Salter D, Choo C, Chilvers E R, Dransfield I, Donnelly S C, Strieter R, Haslett C. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Medicine 1999; 5(6)662–668
   PubMed Web of Science ®Google Scholar
• Bozzo C, Bellomo G, Silengo L, Tarone G, Altruda F. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadher-ent conditions. Exp. Cell. Res. 1997; 237(2)326–337
   PubMed Web of Science ®Google Scholar
• De la Fuente M -T, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A. Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. Leukemia 1999; 13(2)266–274
   PubMed Web of Science ®Google Scholar
• Frisch S M, Ruoslahti E. Integrins and anoikis. Curc Opin. Cell Biol. 1997; 9(3)701–706
   PubMed Web of Science ®Google Scholar
• Hungerford J E, Compton M T, Matter M L, Hoffstrom B G, Otey C A. Inhibition of ppl25FAK in cultured fibrob-lasts results in apoptosis. J. Cell Biol. 1996; 135(3)1383–1390
   PubMed Web of Science ®Google Scholar
• Cary L A, Guan J -L. Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. 1999; 4: 102–113
   PubMedGoogle Scholar
• King W G, Mattaliano M D, Chan T O, Tsichlis P N, Brugge J S. Phosphatidylinositol 3–kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Bid. 1997; 17(8)4406–4418
   Web of Science ®Google Scholar
• Ilic D, Almeida E A, Schlaepfer D D, Dazin P, Aizawa S, Damsky C H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53–mediated apoptosis. J. Cell Biol. 1998; 143(2)547–60
   PubMed Web of Science ®Google Scholar
• Schlaepfer D D, Hauck C R, Sieg D J. Signaling through focal adhesion kinase frog. Biophys. Mol. Biol. 1999; 71: 435–78
   PubMed Web of Science ®Google Scholar
• Rodeck U, Jost M, DuHadaway J, Kari C, Jensen P J, Risse B, Ewert D L. Regulation of Bcl-XI expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc. Nat. Acad. Sci. USA 1997; 94(10)5067–5072
   PubMed Web of Science ®Google Scholar
• Hazlehurst L A, Wisner L, Dalton W S. Activation of (31 integrin induces intrinsic drug resistance in the myeloma 8226 cell line: correlation with decreased proliferative index and increased p27 levels. Proc AACR 1999; 40: 324
   Google Scholar